{"entity":{"type":"insider","cik":"0001612095","url":"/insider/0001612095","json_url":"/insider/0001612095.json","name":"Haqq Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":50,"n_filings":34,"first":"2015-06-01","last":"2019-02-19","span_basis":"filed_date"},"name_variants":[{"name":"Haqq Christopher","source":"filing","n_filings":34,"first_seen":"2015-06-01","last_seen":"2019-02-19"}],"transactions":[{"id":8691904,"accession":"0001209191-19-011187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-011187","line_url":"/filing/0001209191-19-011187#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":775.0,"shares_display":"775","price_per_share":39.59,"price_display":"39.59","price_state":"stated","total_value":30682.25,"total_display":"30,682.25","total_whole":"30,682","shares_owned_after":271943.0,"shares_owned_after_display":"271,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-15","filed_date":"2019-02-19","scope":"insider"},{"id":7836184,"accession":"0001209191-19-009116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-009116","line_url":"/filing/0001209191-19-009116#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13975.0,"shares_display":"13,975","price_per_share":38.55,"price_display":"38.55","price_state":"stated","total_value":538736.25,"total_display":"538,736.25","total_whole":"538,736","shares_owned_after":272718.0,"shares_owned_after_display":"272,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-11","filed_date":"2019-02-11","scope":"insider"},{"id":8644218,"accession":"0001209191-19-008526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-008526","line_url":"/filing/0001209191-19-008526","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12375.0,"shares_display":"12,375","price_per_share":38.619920808080806,"price_display":"38.62","price_state":"stated","total_value":477921.52,"total_display":"477,921.52","total_whole":"477,922","shares_owned_after":273205.0,"shares_owned_after_display":"273,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-06","filed_date":"2019-02-08","scope":"insider","n_lines":2},{"id":6708354,"accession":"0001209191-18-058763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-058763","line_url":"/filing/0001209191-18-058763#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":775.0,"shares_display":"775","price_per_share":33.81,"price_display":"33.81","price_state":"stated","total_value":26202.75,"total_display":"26,202.75","total_whole":"26,203","shares_owned_after":285580.0,"shares_owned_after_display":"285,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-15","scope":"insider"},{"id":5966112,"accession":"0001209191-18-052465","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-052465","line_url":"/filing/0001209191-18-052465#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13500.0,"shares_display":"13,500","price_per_share":43.08,"price_display":"43.08","price_state":"stated","total_value":581580.0,"total_display":"581,580.00","total_whole":"581,580","shares_owned_after":286355.0,"shares_owned_after_display":"286,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-26","filed_date":"2018-09-27","scope":"insider"},{"id":6765448,"accession":"0001209191-18-052162","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-052162","line_url":"/filing/0001209191-18-052162","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13500.0,"shares_display":"13,500","price_per_share":40.51148148148148,"price_display":"40.51","price_state":"stated","total_value":546905.0,"total_display":"546,905.00","total_whole":"546,905","shares_owned_after":303355.0,"shares_owned_after_display":"303,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-25","filed_date":"2018-09-25","scope":"insider","n_lines":2},{"id":6765443,"accession":"0001209191-18-052162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-052162","line_url":"/filing/0001209191-18-052162","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":39.912527222222224,"price_display":"39.91","price_state":"stated","total_value":718425.49,"total_display":"718,425.49","total_whole":"718,425","shares_owned_after":317286.0,"shares_owned_after_display":"317,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-24","filed_date":"2018-09-25","scope":"insider","n_lines":2},{"id":6337018,"accession":"0001209191-18-047107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-047107","line_url":"/filing/0001209191-18-047107#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":775.0,"shares_display":"775","price_per_share":37.54,"price_display":"37.54","price_state":"stated","total_value":29093.5,"total_display":"29,093.50","total_whole":"29,094","shares_owned_after":331355.0,"shares_owned_after_display":"331,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-16","scope":"insider"},{"id":6235439,"accession":"0001209191-18-030722","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-030722","line_url":"/filing/0001209191-18-030722","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25775.0,"shares_display":"25,775","price_per_share":45.295069641125124,"price_display":"45.30","price_state":"stated","total_value":1167480.42,"total_display":"1,167,480.42","total_whole":"1,167,480","shares_owned_after":341382.0,"shares_owned_after_display":"341,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider","n_lines":3},{"id":6100072,"accession":"0001209191-18-021728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-021728","line_url":"/filing/0001209191-18-021728","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18327.0,"shares_display":"18,327","price_per_share":39.791810989250834,"price_display":"39.79","price_state":"stated","total_value":729264.52,"total_display":"729,264.52","total_whole":"729,265","shares_owned_after":334005.0,"shares_owned_after_display":"334,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-26","filed_date":"2018-03-27","scope":"insider","n_lines":2},{"id":4872537,"accession":"0001209191-17-061608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-061608","line_url":"/filing/0001209191-17-061608#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1604.0,"shares_display":"1,604","price_per_share":13.36,"price_display":"13.36","price_state":"stated","total_value":21429.44,"total_display":"21,429.44","total_whole":"21,429","shares_owned_after":342530.0,"shares_owned_after_display":"342,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-15","filed_date":"2017-11-17","scope":"insider"},{"id":4325659,"accession":"0001209191-17-057159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-057159","line_url":"/filing/0001209191-17-057159#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":14.35,"price_display":"14.35","price_state":"stated","total_value":86100.0,"total_display":"86,100.00","total_whole":"86,100","shares_owned_after":343305.0,"shares_owned_after_display":"343,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-17","scope":"insider"},{"id":4542280,"accession":"0001209191-17-053206","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-053206","line_url":"/filing/0001209191-17-053206#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":91800.0,"total_display":"91,800.00","total_whole":"91,800","shares_owned_after":349305.0,"shares_owned_after_display":"349,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-18","scope":"insider"},{"id":4267863,"accession":"0001209191-17-049448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-049448","line_url":"/filing/0001209191-17-049448#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7604.0,"shares_display":"7,604","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":112159.0,"total_display":"112,159.00","total_whole":"112,159","shares_owned_after":355305.0,"shares_owned_after_display":"355,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-08-17","scope":"insider"},{"id":4870769,"accession":"0001209191-17-045509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-045509","line_url":"/filing/0001209191-17-045509#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":14.92,"price_display":"14.92","price_state":"stated","total_value":89520.0,"total_display":"89,520.00","total_whole":"89,520","shares_owned_after":362080.0,"shares_owned_after_display":"362,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-17","filed_date":"2017-07-18","scope":"insider"},{"id":4905757,"accession":"0001209191-17-040561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-040561","line_url":"/filing/0001209191-17-040561#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":12.65,"price_display":"12.65","price_state":"stated","total_value":75900.0,"total_display":"75,900.00","total_whole":"75,900","shares_owned_after":368080.0,"shares_owned_after_display":"368,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-15","filed_date":"2017-06-16","scope":"insider"},{"id":4988897,"accession":"0001209191-17-033195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-033195","line_url":"/filing/0001209191-17-033195#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7604.0,"shares_display":"7,604","price_per_share":14.99,"price_display":"14.99","price_state":"stated","total_value":113983.96,"total_display":"113,983.96","total_whole":"113,984","shares_owned_after":374080.0,"shares_owned_after_display":"374,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider"},{"id":4657534,"accession":"0001209191-17-027470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-027470","line_url":"/filing/0001209191-17-027470#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":17.28,"price_display":"17.28","price_state":"stated","total_value":103680.0,"total_display":"103,680.00","total_whole":"103,680","shares_owned_after":380855.0,"shares_owned_after_display":"380,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-17","filed_date":"2017-04-19","scope":"insider"},{"id":5034064,"accession":"0001209191-17-021452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021452","line_url":"/filing/0001209191-17-021452#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":19.6,"price_display":"19.60","price_state":"stated","total_value":117600.0,"total_display":"117,600.00","total_whole":"117,600","shares_owned_after":386855.0,"shares_owned_after_display":"386,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-17","scope":"insider"},{"id":4411024,"accession":"0001209191-17-011764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-011764","line_url":"/filing/0001209191-17-011764#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7604.0,"shares_display":"7,604","price_per_share":15.49,"price_display":"15.49","price_state":"stated","total_value":117785.96,"total_display":"117,785.96","total_whole":"117,786","shares_owned_after":392855.0,"shares_owned_after_display":"392,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-02-16","scope":"insider"},{"id":5309068,"accession":"0001209191-17-009718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-009718","line_url":"/filing/0001209191-17-009718#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13975.0,"shares_display":"13,975","price_per_share":15.46,"price_display":"15.46","price_state":"stated","total_value":216053.5,"total_display":"216,053.50","total_whole":"216,054","shares_owned_after":399630.0,"shares_owned_after_display":"399,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-10","scope":"insider"},{"id":5031351,"accession":"0001209191-17-004333","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-004333","line_url":"/filing/0001209191-17-004333#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (EVP, R&D & Chief Scientific Of)","role_mark":"O","role_mark_label":"Officer (EVP, R&D & Chief Scientific Of)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D & Chief Scientific Of","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":85620.0,"total_display":"85,620.00","total_whole":"85,620","shares_owned_after":364105.0,"shares_owned_after_display":"364,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-18","scope":"insider"},{"id":3049558,"accession":"0001209191-16-155509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-155509","line_url":"/filing/0001209191-16-155509#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":15.4,"price_display":"15.40","price_state":"stated","total_value":92400.0,"total_display":"92,400.00","total_whole":"92,400","shares_owned_after":370105.0,"shares_owned_after_display":"370,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-15","scope":"insider"},{"id":3004465,"accession":"0001209191-16-151797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151797","line_url":"/filing/0001209191-16-151797#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7068.0,"shares_display":"7,068","price_per_share":17.85,"price_display":"17.85","price_state":"stated","total_value":126163.8,"total_display":"126,163.80","total_whole":"126,164","shares_owned_after":376105.0,"shares_owned_after_display":"376,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-22","scope":"insider"},{"id":2673533,"accession":"0001209191-16-150914","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-150914","line_url":"/filing/0001209191-16-150914#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1604.0,"shares_display":"1,604","price_per_share":19.95,"price_display":"19.95","price_state":"stated","total_value":31999.8,"total_display":"31,999.80","total_whole":"32,000","shares_owned_after":383173.0,"shares_owned_after_display":"383,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-17","scope":"insider"},{"id":2131290,"accession":"0001209191-16-137680","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-137680","line_url":"/filing/0001209191-16-137680","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1346.0,"shares_display":"1,346","price_per_share":22.31848439821694,"price_display":"22.32","price_state":"stated","total_value":30040.68,"total_display":"30,040.68","total_whole":"30,041","shares_owned_after":293948.0,"shares_owned_after_display":"293,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider","n_lines":2},{"id":2784106,"accession":"0001209191-16-121434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-121434","line_url":"/filing/0001209191-16-121434#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1605.0,"shares_display":"1,605","price_per_share":15.57,"price_display":"15.57","price_state":"stated","total_value":24989.85,"total_display":"24,989.85","total_whole":"24,990","shares_owned_after":294465.0,"shares_owned_after_display":"294,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"},{"id":2771297,"accession":"0001209191-16-100248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-100248","line_url":"/filing/0001209191-16-100248#line-2","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3208.0,"shares_display":"3,208","price_per_share":15.43,"price_display":"15.43","price_state":"stated","total_value":49499.44,"total_display":"49,499.44","total_whole":"49,499","shares_owned_after":295240.0,"shares_owned_after_display":"295,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-16","filed_date":"2016-02-18","scope":"insider"},{"id":8604153,"accession":"0001209191-15-068906","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-068906","line_url":"/filing/0001209191-15-068906","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":41.9922,"price_display":"41.99","price_state":"stated","total_value":209961.0,"total_display":"209,961.00","total_whole":"209,961","shares_owned_after":240890.0,"shares_owned_after_display":"240,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-31","filed_date":"2015-09-01","scope":"insider","n_lines":2},{"id":8603971,"accession":"0001209191-15-067012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-067012","line_url":"/filing/0001209191-15-067012","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1604.0,"shares_display":"1,604","price_per_share":45.905236907730675,"price_display":"45.91","price_state":"stated","total_value":73632.0,"total_display":"73,632.00","total_whole":"73,632","shares_owned_after":246190.0,"shares_owned_after_display":"246,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-17","filed_date":"2015-08-19","scope":"insider","n_lines":2},{"id":8904168,"accession":"0001209191-15-063312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-063312","line_url":"/filing/0001209191-15-063312#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":55.43,"price_display":"55.43","price_state":"stated","total_value":138575.0,"total_display":"138,575.00","total_whole":"138,575","shares_owned_after":246665.0,"shares_owned_after_display":"246,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-31","filed_date":"2015-08-03","scope":"insider"},{"id":8866793,"accession":"0001209191-15-061030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-061030","line_url":"/filing/0001209191-15-061030","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":62.9412,"price_display":"62.94","price_state":"stated","total_value":157353.0,"total_display":"157,353.00","total_whole":"157,353","shares_owned_after":249965.0,"shares_owned_after_display":"249,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-15","filed_date":"2015-07-15","scope":"insider","n_lines":2},{"id":8827235,"accession":"0001209191-15-059119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-059119","line_url":"/filing/0001209191-15-059119","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":51.6784,"price_display":"51.68","price_state":"stated","total_value":129196.0,"total_display":"129,196.00","total_whole":"129,196","shares_owned_after":251665.0,"shares_owned_after_display":"251,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-02","scope":"insider","n_lines":2},{"id":8750640,"accession":"0001209191-15-054001","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-054001","line_url":"/filing/0001209191-15-054001","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":46.41546666666667,"price_display":"46.42","price_state":"stated","total_value":348116.0,"total_display":"348,116.00","total_whole":"348,116","shares_owned_after":255265.0,"shares_owned_after_display":"255,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-16","scope":"insider","n_lines":3},{"id":8720217,"accession":"0001209191-15-048430","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-048430","line_url":"/filing/0001209191-15-048430","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001612095","owner_name":"Haqq Christopher","owner_display_name":"Haqq Christopher","owner_url":"/insider/0001612095","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":41.4658,"price_display":"41.47","price_state":"stated","total_value":103664.5,"total_display":"103,664.50","total_whole":"103,665","shares_owned_after":262815.0,"shares_owned_after_display":"262,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-01","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":50,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":50,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":50},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (EVP, R&D & Chief Scientific Of)","n_filings":34,"first_seen":"2015-06-01","last_seen":"2019-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612095","retrieved_at":"2026-08-24T17:33:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}